New Brunswick, NJ (August 17, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 10:40 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Press Contacts:
Cristal Downing
(732) 524-3283
(908) 616-6250 (M)
Investor Contacts:
Jennifer McIntyre
(732) 524-3922